Chief Legal and Compliance Officer and Secretary · PLIANT THERAPEUTICS, INC. (PLRX)

Mike Ouimette

A named executive officer of PLIANT THERAPEUTICS in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,994,260

Salary $442,936Stock awards $549,360

FY2023: $3,316,978

5th of 5 named executive officers at Pliant Therapeutics by FY2024 total.

5 named officers on file for PLIANT THERAPEUTICS, FY2024

Mike Ouimette’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 7 equity grants, each cited to its filing
  • PLRX’s disclosed peer group of 22 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PLIANT THERAPEUTICS’s whole pay program stands against its peers

  • PLIANT THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PLRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 23, 2025 (DEF 14A).

Free

Get Mike Ouimette’s full pay file as a PDF — free

More than this page: up to 10 years of Mike’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Mike Ouimette compensation by year

PLIANT THERAPEUTICS Summary Compensation Table · all 4 fiscal years held
In US dollars, as PLIANT THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024
Salary$362,693$398,000$425,900$442,936
Bonus$0$0$0$0
Stock awards$0$1,270,206$1,351,350$549,360
Option awards$267,054$680,993$1,359,600$811,440
Non-equity incentive$174,092$191,040$170,360$177,174
Pension and deferred compensation$0$0$0$0
All other$1,200$2,009$9,768$13,350
Total$805,039$2,542,248$3,316,978$1,994,260

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PLIANT THERAPEUTICS, INC. DEF 14A filed April 23, 2025, accession 0001746473-25-000089, and prior-year filings. Open the filing on EDGAR.

How this page was built: the PLIANT THERAPEUTICS, INC. filed document, accession 0001746473-25-000089. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2025.

$805K
$2.5M
$3.3M
$2.0M
FY21
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU31,500$414,855—
RSU26,000$342,420—
Option324—$26.50
Option28,646—$34.65
Option48,563—$17.44
Option23,563—$11.86

Per the Outstanding Equity Awards at Fiscal Year-End table in PLIANT THERAPEUTICS, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

PLIANT THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Bernard CouliePresident, Chief Executive Officer and Director$6,614,704
Keith CummingsChief Financial Officer$3,099,874
Éric LefebvreChief Medical Officer$2,615,618
Hans HullChief Business Officer$2,015,324
Mike Ouimette · this pageChief Legal and Compliance Officer and Secretary$1,994,260

The full PLIANT THERAPEUTICS compensation record

free company brief

This page is one person within PLIANT THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the PLIANT THERAPEUTICS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PLIANT THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mike Ouimette's compensation dossier · One-time report. No refunds.